Team’s AI agent to speed Alzheimer’s treatment Newswise (Press Release) 2d Newswise (Press Release) 2d
Mounjaro sales double this year as obesity drug boom prevails, says maker Evening Standard 2d Evening Standard 2d Article paywall
Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer PR Newswire (Press Release) 4d PR Newswire (Press Release) 4d
Abbott laboratories vs. Eli Lilly: Which healthcare stock is a better buy in 2026? The Motley Fool 5d The Motley Fool 5d
Watch out, Eli Lilly and Novo Nordisk: Amgen's monthly weight loss drug has 6 Phase 3 trials running -- and it's coming for your patients The Motley Fool 12:59 Wed, 29 Jul The Motley Fool 12:59 Wed, 29 Jul
Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem The Motley Fool 23:40 Fri, 07 Aug
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound The Motley Fool 20:36 Fri, 07 Aug
CVS Health (CVS) Is Down 8.6% After Raising EPS Outlook And Expanding GLP-1 Offerings - Has The Bull Case Changed? Simply Wall St 08:42 Fri, 07 Aug
Will Strong Q2 Results and Higher 2026 Outlook Change Eli Lilly's (LLY) Narrative? Simply Wall St 08:42 Fri, 07 Aug
Eli Lilly, Novo Nordisk Antitrust Suit Tossed By Texas Judge Law360 20:19 Thu, 06 Aug Article paywall
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight PR Newswire (Press Release) 15:33 Thu, 06 Aug
Eli Lilly raises 2026 outlook again as Q2 soars past estimates Pharmaceutical Technology 11:19 Thu, 06 Aug